Sign in
4

Changes in Ownership

Monopar Therapeutics Filed Acc 0001437749-25-006736

Chief Executive Officer gave up 1,759 shares (to pay taxes)

  • Chief Executive Officer acquired 6,002 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Robinson Chandler Chief Executive Officer 2025-03-04 Option exercise +6,002 64,850 D: show line 1 in the form
Robinson Chandler Chief Executive Officer 2025-03-04 Shares withheld for taxes −1,759 $31.70 $55,760 63,091 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Robinson Chandler Chief Executive Officer 2025-03-04 Grant or award · Stock Options +85,759 85,759 D: show line 3 in the form
Robinson Chandler Chief Executive Officer 2025-03-04 Grant or award · Restricted Stock Units +79,899 104,777 D: show line 4 in the form
Robinson Chandler Chief Executive Officer 2025-03-04 Option exercise · Restricted Stock Units −6,002 98,775 D: show line 5 in the form
Loading xslF345X05/rdgdoc.xml…